Visceral abdominal obesity is associated with an increased risk of irritable bowel syndrome. (Q53031023)

10 May 2018

title

Visceral abdominal obesity is associated with an increased risk of irritable bowel syndrome. (English)

1 reference

10 May 2018

0 references

Chang Geun Lee

1

1 reference

10 May 2018

Jun Kyu Lee

2

1 reference

10 May 2018

Yun-Seong Kang

3

1 reference

10 May 2018

Seungmin Shin

4

1 reference

10 May 2018

Jae Hak Kim

5

1 reference

10 May 2018

Yun Jeong Lim

6

1 reference

10 May 2018

Moon-Soo Koh

7

1 reference

10 May 2018

Jin Ho Lee

8

1 reference

10 May 2018

Hyoun Woo Kang

9

1 reference

10 May 2018

language of work or name

English

0 references

publication date

13 January 2015

1 reference

10 May 2018

The American Journal of Gastroenterology

published in

1 reference

10 May 2018

volume

110

1 reference

10 May 2018

page(s)

310-319

1 reference

10 May 2018

issue

2

1 reference

10 May 2018

https://api.crossref.org/works/10.1038%2FAJG.2014.422

1 reference

Obesity, metabolic syndrome, and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.422

Obesity, metabolic syndrome, and type 2 diabetes: emerging epidemics and their cardiovascular implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.422

Obesity and gastrointestinal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.422

The role of obesity in gastrointestinal cancer: evidence and opinion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.422

Gastrointestinal complications of obesity: non-alcoholic fatty liver disease (NAFLD) and its sequelae

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.422

Gastrointestinal symptoms and obesity: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.422

Obesity and chronic gastrointestinal tract symptoms in young adults: a birth cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.422

Obesity is associated with increased risk of gastrointestinal symptoms: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.422

Association of upper and lower gastrointestinal tract symptoms with body mass index in an Australian cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.422

Extra-intestinal manifestations associated with irritable bowel syndrome: a twin study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.422

Subcutaneous and visceral adipose tissue gene expression of serum adipokines that predict type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.422

Visceral obesity: the link among inflammation, hypertension, and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.422

Comparison of Manning, Rome I, II, and III, and Asian diagnostic criteria: report of the Multicentric Indian Irritable Bowel Syndrome (MIIBS) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.422

Measuring body fat distribution and content in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.422

Metabolic syndrome and visceral obesity as risk factors for reflux oesophagitis: a cross-sectional case-control study of 7078 Koreans undergoing health check-ups

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.422

Abdominal visceral adipose tissue volume is associated with increased risk of erosive esophagitis in men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.422

The endoscopic assessment of esophagitis: a progress report on observer agreement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.422

Is Rome III Criteria for Irritable Bowel Syndrome More Useful Than Rome II Criteria in Korea?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.422

Functional Gastrointestinal Disorders Diagnosed by Rome III Questionnaire in Korea

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.422

Rome III Criteria for Functional Gastrointestinal Disorders: Is There a Need for a Better Definition?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.422

The irritable bowel syndrome: a paroxysmal motor disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.422

The role of stress on physiologic responses and clinical symptoms in irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.422

Immune activation in patients with irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.422

The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.422

Gastrointestinal symptoms and diseases related to obesity: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.422

Morphological and inflammatory changes in visceral adipose tissue during obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.422

Inflamed fat: what starts the fire?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.422

Low-grade inflammation plays a pivotal role in gastrointestinal dysfunction in irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.422

Infection, inflammation, and the irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.422

Clinical and subclinical intestinal inflammation assessed by the mucosal patch technique: studies of mucosal neutrophil and eosinophil activation in inflammatory bowel diseases and irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.422

Brain-gut microbiome interactions and functional bowel disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.422

The role and influence of gut microbiota in pathogenesis and management of obesity and metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.422

Methane and hydrogen positivity on breath test is associated with greater body mass index and body fat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.422

An obesity-associated gut microbiome with increased capacity for energy harvest

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.422

Methane, a gas produced by enteric bacteria, slows intestinal transit and augments small intestinal contractile activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.422

IBS subjects with methane on lactulose breath test have lower postprandial serotonin levels than subjects with hydrogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.422

The degree of breath methane production in IBS correlates with the severity of constipation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.422

Subjects with diarrhea-predominant IBS have increased rectal permeability responsive to tryptase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.422

Mucosal mast cell count is associated with intestinal permeability in patients with diarrhea predominant irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.422

Women with diarrhoea-predominant irritable bowel syndrome show an increased pressure response to 35% carbon dioxide stress challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.422

Alterations of gastrointestinal motility in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.422

Effects of gastrointestinal motility on obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.422

Human adipose tissue-derived multipotent stem cells differentiate in vitro and in vivo into osteocyte-like cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.422

T-lymphocyte infiltration in visceral adipose tissue: a primary event in adipose tissue inflammation and the development of obesity-mediated insulin resistance

21 January 2018

1 reference

12 December 2020

A high-fat meal induces low-grade endotoxemia: evidence of a novel mechanism of postprandial inflammation

1 reference

12 December 2020

Gastrointestinal disorders and symptoms: does body mass index matter?

1 reference

12 December 2020

Abnormal propagation pattern of duodenal pressure waves in the irritable bowel syndrome (IBS) [correction of (IBD)]

1 reference

12 December 2020

Adipose tissue expansion and the development of obesity: influence of dietary fat type

1 reference

12 December 2020

Risk of gastrointestinal malignancies and mechanisms of cancer development with obesity and its treatment

1 reference

12 December 2020

Obesity, inflammation, and the gut microbiota

1 reference

12 December 2020

[Inflammation, adipokines and obesity]

1 reference

12 December 2020

Analysis of the Fecal Microbiota of Irritable Bowel Syndrome Patients and Healthy Controls with Real-Time PCR

1 reference

12 December 2020

Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome

1 reference

12 December 2020

Rectal distention testing in patients with irritable bowel syndrome: sensitivity, specificity, and predictive values of pain sensory thresholds

1 reference

12 December 2020

[The role of adipose tissue and macrophages in chronic inflammation associated with obesity: clinical implications].

1 reference

12 December 2020

Full-thickness biopsy of the jejunum reveals inflammation and enteric neuropathy in irritable bowel syndrome

1 reference

12 December 2020

Tolerance for rectosigmoid distention in irritable bowel syndrome

1 reference

12 December 2020

Bristol scale stool form. A still valid help in medical practice and clinical research

1 reference

12 December 2020

Prevalence of gastrointestinal symptoms in obese and normal weight binge eaters.

1 reference

12 December 2020

Psychosocial factors are linked to functional gastrointestinal disorders: a population based nested case-control study

1 reference

12 December 2020

Identifiers

DOI

10.1038/AJG.2014.422

1 reference

10 May 2018

PubMed ID

25583325

1 reference

10 May 2018